PHARMA

0.245

(%)

Quarterly rpt on consolidated results for the financial period ended 31 Dec 2025

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2025
Quarter 4 Qtr
Quarterly report for the financial period ended 31 Dec 2025
The figures have not been audited

Attachments

Q4 2025 Bursa Announcement.pdf
462.1 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2025

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Dec 2025
31 Dec 2024
31 Dec 2025
31 Dec 2024
MYR'000
MYR'000
MYR'000
MYR'000
1 Revenue
938,277
926,442
3,927,753
3,759,479
2 Profit/(loss) before tax
11,443
13,317
74,737
194,180
3 Profit/(loss) for the period
8,732
2,450
50,684
133,794
4 Profit/(loss) attributable to ordinary equity holders of the parent
7,695
2,347
48,510
131,822
5 Basic earnings/(loss) per share (Subunit)
0.21
0.16
1.34
9.15
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent
0.0663
-0.1188

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 23 Feb 2026
Category Financial Results
Reference Number FRA-11022026-00012